Vice President, Investor Relations – Corporate Communications

Janux Therapeutics

. Develop and execute a comprehensive investor relations and corporate communications strategy aligned with Janux’s mission, pipeline priorities, business objectives, and long-term value creation .

Posted 10/9/2026full-timeSan Diego • California • United StatesLead💰 $317,000 - $347,000 per yearWebsite

Core Competencies

Role fit

Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in developing and executing investor relations and corporate communications strategies within the biotechnology sector, with a strong focus on oncology and advanced biologics. Proven ability to build relationships with institutional investors and effectively communicate complex scientific and business narratives.

Highest-signal resume keywords

Investor Relations Strategy DevelopmentCorporate Communications LeadershipOncology ExperienceSEC Regulations KnowledgeCross-Functional Collaboration

ATS Keywords

Tailor your resume

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills

Investor EngagementMessage DevelopmentEarnings CommunicationsCapital Markets UnderstandingBiotech Valuation DriversReg FD CompliancePerformance MeasurementScientific Narrative TranslationInvestor Targeting StrategiesPublic Disclosures

Soft Skills

Exceptional Communication SkillsInfluencing Senior StakeholdersExecutive PresenceHigh IntegrityStrong Writing and Editorial Judgment

Tools & Technologies

IR PlatformsCommunications ToolsPerformance Oversight ToolsBudget Management Tools

Industry Keywords

BiotechnologyPharmaceuticalLife SciencesClinical MilestonesCorporate GovernanceInvestor Sentiment MonitoringAnalyst RelationsHealthcare Media RelationsT-Cell EngagersAntibody-Drug Conjugates

About the role

Key responsibilities & impact

Develop and execute a comprehensive investor relations and corporate communications strategy aligned with Janux’s mission, pipeline priorities, business objectives, and long-term value creation
Shape Janux’s corporate narrative, brand identity, positioning, and messaging frameworks
Build and cultivate relationships with institutional investors, analysts, and banking partners
Lead investor engagement and targeting activities, including conferences, non-deal roadshows, R&D/Analyst Days, KOL webinars, analyst meetings, and other investor events
Develop and execute shareholder targeting and ownership strategies
Prepare senior leadership for investor conferences, non-deal roadshows, and high-profile investor interactions
Lead message development, FAQs, Q&A documents, briefing materials, and response frameworks
Oversee investor-facing and public communications, including earnings materials, investor presentations, scripts, press releases, website content, talking points, and executive briefing materials
Lead communications planning around clinical and regulatory milestones, corporate transactions, partnerships, and financing activities
Manage an integrated communications calendar and agenda
Serve as a designated external representative to the investment community and media
Monitor investor sentiment, stock performance, analyst commentary and coverage, peer performance, and capital markets trends
Track sell-side models and compare them with internal forecasts
Partner with Legal and Finance on external communications, public disclosures, earnings communications, SEC disclosures, Reg FD requirements, and material event communications
Provide strategic insights and recommendations to executive leadership and the Board
Partner cross-functionally with Clinical, Project Management, Regulatory, HR, Finance, and Legal
Lead external IR and communications agencies and consultants, including scope, budgets, performance oversight, and program measurement
Report directly to the Chief Corporate and Business Development Officer
Advise executive leadership and the Board on investor sentiment, shareholder communications, market positioning, and reputational risk
Perform other duties as necessary

Requirements

What you’ll need

Bachelor’s degree in Finance, Biology, Communications, or related field required; advanced degree (MBA, PhD, or MS) preferred
Minimum of 12-15 years of progressive leadership experience in investor relations and/or corporate communications within the biotechnology, pharmaceutical, or life sciences industry
Substantial leadership experience
Significant oncology experience required
Demonstrated experience supporting innovative therapeutic platforms and complex modalities such as T-cell engagers (TCEs), bispecific antibodies, CAR-T/cell therapies, antibody-drug conjugates (ADCs), or other advanced biologics
Autoimmune experience highly preferred
Exceptional communication skills and ability to translate complex scientific and business developments into clear, compelling narratives
Strong understanding of capital markets, investor behavior, and biotech valuation drivers
Deep knowledge of SEC regulations, Reg FD, disclosure obligations, corporate governance practices, and IR best practices
Established relationships with key investors, analysts, and media in the healthcare/life sciences space
Experience with IR and communications platforms and tools, managing external agencies, budgets, and performance measurement
Ability to work in a fast-paced, science-driven environment
Ability to influence and partner with cross-functional teams and senior stakeholders, with executive presence and demonstrated ability to counsel senior leaders
Experience building or significantly developing investor relations and corporate communications capabilities, infrastructure, and best practices
Experience supporting publicly traded biotechnology companies through significant clinical, regulatory, corporate development, and financing milestones
Strong writing and editorial judgment across scientific, corporate, investor, media, and employee audiences
High level of integrity and commitment to ethical standards
United States work authorization required

Benefits

Comp & perks

Annual bonus program
Incentive stock option plan
401k plan with flat non-elective employer contribution
Comprehensive medical insurance with 90-100% employer-paid premiums
Dental and vision insurance
HSA, FSA, and supplemental insurance plans (life, disability, accident, critical illness, hospital indemnity)
Unlimited PTO
Generous holiday schedule, including summer and winter company shutdown
Relocation assistance
Stock options
Restricted stock units
Stock purchase plan (ESPP)
Target bonus
Remote permitted upon approval
Ability to travel up to 25% for meetings or site visits